{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T06:39:27Z","timestamp":1781332767050,"version":"3.54.1"},"reference-count":15,"publisher":"European Respiratory Society (ERS)","issue":"4","funder":[{"DOI":"10.13039\/501100001721","name":"Rijksuniversiteit Groningen","doi-asserted-by":"publisher","award":["Eric Bleumink Fund"],"award-info":[{"award-number":["Eric Bleumink Fund"]}],"id":[{"id":"10.13039\/501100001721","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005075","name":"Universitair Medisch Centrum Groningen","doi-asserted-by":"publisher","award":["KFF scholarship"],"award-info":[{"award-number":["KFF scholarship"]}],"id":[{"id":"10.13039\/501100005075","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["publications.ersnet.org"],"crossmark-restriction":true},"short-container-title":["Eur Respir J"],"accepted":{"date-parts":[[2018,12,28]]},"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1183\/13993003.02107-2018","type":"journal-article","created":{"date-parts":[[2019,1,17]],"date-time":"2019-01-17T13:31:28Z","timestamp":1547731888000},"page":"1802107","update-policy":"https:\/\/doi.org\/10.1183\/ers-crossmark-policy","source":"Crossref","is-referenced-by-count":22,"title":["Levofloxacin pharmacokinetics, pharmacodynamics and outcome in multidrug-resistant tuberculosis patients"],"prefix":"10.1183","volume":"53","author":[{"given":"Samiksha","family":"Ghimire","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhagwan","family":"Maharjan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erwin M.","family":"Jongedijk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos G.W.","family":"Kosterink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gokarna R.","family":"Ghimire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daan J.","family":"Touw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tjip S.","family":"van der Werf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhabana","family":"Shrestha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan-Willem C.","family":"Alffenaar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"81","published-online":{"date-parts":[[2019,1,17]]},"reference":[{"key":"2024102100471295000_53.4.1802107.1","unstructured":"World Health Organization . Rapid Communication: Key changes to treatment of multi-drug and rifampicin- resistant tuberculosis (MDR\/RR-TB) . www.who.int\/tb\/publications\/2018\/WHO_RapidCommunicationMDRTB.pdf?ua=1. Date last accessed: September, 2018. Date last updated: 2018."},{"key":"2024102100471295000_53.4.1802107.2","doi-asserted-by":"crossref","first-page":"1602308","DOI":"10.1183\/13993003.02308-2016","article-title":"World Health Organization treatment guidelines for drug-resistant tuberculosis, 2016 update","volume":"49 .","author":"Falzon","year":"2017","journal-title":"Eur Respir J"},{"key":"2024102100471295000_53.4.1802107.3","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00176610"},{"key":"2024102100471295000_53.4.1802107.4","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciu572"},{"key":"2024102100471295000_53.4.1802107.5","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00173-2017"},{"key":"2024102100471295000_53.4.1802107.6","doi-asserted-by":"crossref","unstructured":"Peloquin CA , Phillips PP , Mitnick CD , et\u00a0al. Increased doses lead to higher drug exposures of levofloxacin for the treatment of tuberculosis. Antimicrob Agents Chemother 2018: AAC.00770-18.","DOI":"10.1128\/AAC.00770-18"},{"key":"2024102100471295000_53.4.1802107.7","doi-asserted-by":"publisher","DOI":"10.1186\/s13063-017-2292-x"},{"key":"2024102100471295000_53.4.1802107.8","unstructured":"Horsburgh CR . Efficacy and Safety of Levofloxacin in the treatment of MDR-TB (Opti-Q) . https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01918397. Date last accessed: December, 2018. Date last updated: 2018."},{"issue":"Suppl. 3","key":"2024102100471295000_53.4.1802107.9","doi-asserted-by":"crossref","first-page":"S293","DOI":"10.1093\/cid\/ciy611","article-title":"Levofloxacin pharmacokinetics\/pharmacodynamics, dosing, susceptibility breakpoints, and artificial intelligence in the treatment of multidrug-resistant tuberculosis","volume":"67","author":"Deshpande","year":"2018","journal-title":"Clin Infect Dis"},{"key":"2024102100471295000_53.4.1802107.10","doi-asserted-by":"publisher","DOI":"10.17145\/jab.18.004"},{"key":"2024102100471295000_53.4.1802107.11","doi-asserted-by":"crossref","first-page":"00343-27","DOI":"10.1128\/AAC.00343-17","article-title":"Pharmacokinetics of levofloxacin in multidrug-and extensively drug-resistant tuberculosis patients","volume":"61","author":"van't Boveneind-Vrubleuskaya","year":"2017","journal-title":"Antimicrob Agents Chemother"},{"key":"2024102100471295000_53.4.1802107.12","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201303-0604OC"},{"key":"2024102100471295000_53.4.1802107.13","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00061-2017"},{"key":"2024102100471295000_53.4.1802107.14","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkw164"},{"key":"2024102100471295000_53.4.1802107.15","unstructured":"US Food and Drug Administration . FDA updates warnings for fluoroquinolone antibiotics on risks of mental health and low blood sugar adverse reactions . 2018 https:\/\/www.fda.gov\/newsevents\/newsroom\/pressannouncements\/ucm612995.htm. Date last accessed: December, 2018. Date last updated: 2018."}],"container-title":["European Respiratory Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1183\/13993003.02107-2018","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,24]],"date-time":"2025-02-24T07:33:47Z","timestamp":1740382427000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.ersnet.org\/lookup\/doi\/10.1183\/13993003.02107-2018"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,1,17]]},"references-count":15,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2019,4,18]]},"published-print":{"date-parts":[[2019,4]]}},"alternative-id":["10.1183\/13993003.02107-2018"],"URL":"https:\/\/doi.org\/10.1183\/13993003.02107-2018","relation":{},"ISSN":["0903-1936","1399-3003"],"issn-type":[{"value":"0903-1936","type":"print"},{"value":"1399-3003","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,1,17]]}}}